1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by NASH Therapeutic Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Vitamin E and Pioglitazone 1.4.3 Ocaliva 1.4.4 Elafibranor 1.4.5 Selonsertib and Cenicriviroc 1.5 Market by Application 1.5.1 Global NASH Therapeutic Drugs Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacy 1.5.3 Online Provider 1.5.4 Retail Pharmacy 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 NASH Therapeutic Drugs Market Perspective (2015-2026) 2.2 NASH Therapeutic Drugs Growth Trends by Regions 2.2.1 NASH Therapeutic Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 NASH Therapeutic Drugs Historic Market Share by Regions (2015-2020) 2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 NASH Therapeutic Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key NASH Therapeutic Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top NASH Therapeutic Drugs Players by Market Size 3.1.1 Global Top NASH Therapeutic Drugs Players by Revenue (2015-2020) 3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global NASH Therapeutic Drugs Market Concentration Ratio 3.2.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2019 3.3 NASH Therapeutic Drugs Key Players Head office and Area Served 3.4 Key Players NASH Therapeutic Drugs Product Solution and Service 3.5 Date of Enter into NASH Therapeutic Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2015-2020) 4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2021-2026) 5 NASH Therapeutic Drugs Breakdown Data by Application (2015-2026) 5.1 Global NASH Therapeutic Drugs Market Size by Application (2015-2020) 5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America NASH Therapeutic Drugs Market Size (2015-2020) 6.2 NASH Therapeutic Drugs Key Players in North America (2019-2020) 6.3 North America NASH Therapeutic Drugs Market Size by Type (2015-2020) 6.4 North America NASH Therapeutic Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe NASH Therapeutic Drugs Market Size (2015-2020) 7.2 NASH Therapeutic Drugs Key Players in Europe (2019-2020) 7.3 Europe NASH Therapeutic Drugs Market Size by Type (2015-2020) 7.4 Europe NASH Therapeutic Drugs Market Size by Application (2015-2020) 8 China 8.1 China NASH Therapeutic Drugs Market Size (2015-2020) 8.2 NASH Therapeutic Drugs Key Players in China (2019-2020) 8.3 China NASH Therapeutic Drugs Market Size by Type (2015-2020) 8.4 China NASH Therapeutic Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan NASH Therapeutic Drugs Market Size (2015-2020) 9.2 NASH Therapeutic Drugs Key Players in Japan (2019-2020) 9.3 Japan NASH Therapeutic Drugs Market Size by Type (2015-2020) 9.4 Japan NASH Therapeutic Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia NASH Therapeutic Drugs Market Size (2015-2020) 10.2 NASH Therapeutic Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia NASH Therapeutic Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia NASH Therapeutic Drugs Market Size by Application (2015-2020) 11 India 11.1 India NASH Therapeutic Drugs Market Size (2015-2020) 11.2 NASH Therapeutic Drugs Key Players in India (2019-2020) 11.3 India NASH Therapeutic Drugs Market Size by Type (2015-2020) 11.4 India NASH Therapeutic Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America NASH Therapeutic Drugs Market Size (2015-2020) 12.2 NASH Therapeutic Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America NASH Therapeutic Drugs Market Size by Type (2015-2020) 12.4 Central & South America NASH Therapeutic Drugs Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Allergan Plc (Tobira) 13.1.1 Allergan Plc (Tobira) Company Details 13.1.2 Allergan Plc (Tobira) Business Overview and Its Total Revenue 13.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction 13.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2015-2020)) 13.1.5 Allergan Plc (Tobira) Recent Development 13.2 Bristol Myers Squibb 13.2.1 Bristol Myers Squibb Company Details 13.2.2 Bristol Myers Squibb Business Overview and Its Total Revenue 13.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction 13.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2015-2020) 13.2.5 Bristol Myers Squibb Recent Development 13.3 Galmed Pharmaceuticals 13.3.1 Galmed Pharmaceuticals Company Details 13.3.2 Galmed Pharmaceuticals Business Overview and Its Total Revenue 13.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction 13.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2015-2020) 13.3.5 Galmed Pharmaceuticals Recent Development 13.4 Genfit SA 13.4.1 Genfit SA Company Details 13.4.2 Genfit SA Business Overview and Its Total Revenue 13.4.3 Genfit SA NASH Therapeutic Drugs Introduction 13.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2015-2020) 13.4.5 Genfit SA Recent Development 13.5 Gilead Sciences, Inc. 13.5.1 Gilead Sciences, Inc. Company Details 13.5.2 Gilead Sciences, Inc. Business Overview and Its Total Revenue 13.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction 13.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2015-2020) 13.5.5 Gilead Sciences, Inc. Recent Development 13.6 Intercept Pharmaceuticals, Inc. 13.6.1 Intercept Pharmaceuticals, Inc. Company Details 13.6.2 Intercept Pharmaceuticals, Inc. Business Overview and Its Total Revenue 13.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction 13.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2015-2020) 13.6.5 Intercept Pharmaceuticals, Inc. Recent Development 13.7 Zydus Cadila 13.7.1 Zydus Cadila Company Details 13.7.2 Zydus Cadila Business Overview and Its Total Revenue 13.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction 13.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2015-2020) 13.7.5 Zydus Cadila Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. NASH Therapeutic Drugs Key Market Segments Table 2. Key Players Covered: Ranking by NASH Therapeutic Drugs Revenue Table 3. Ranking of Global Top NASH Therapeutic Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global NASH Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Vitamin E and Pioglitazone Table 6. Key Players of Ocaliva Table 7. Key Players of Elafibranor Table 8. Key Players of Selonsertib and Cenicriviroc Table 9. Global NASH Therapeutic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global NASH Therapeutic Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global NASH Therapeutic Drugs Market Size by Regions (2015-2020) (US$ Million) Table 12. Global NASH Therapeutic Drugs Market Share by Regions (2015-2020) Table 13. Global NASH Therapeutic Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global NASH Therapeutic Drugs Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. NASH Therapeutic Drugs Market Growth Strategy Table 19. Main Points Interviewed from Key NASH Therapeutic Drugs Players Table 20. Global NASH Therapeutic Drugs Revenue by Players (2015-2020) (Million US$) Table 21. Global NASH Therapeutic Drugs Market Share by Players (2015-2020) Table 22. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NASH Therapeutic Drugs as of 2019) Table 23. Global NASH Therapeutic Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players NASH Therapeutic Drugs Product Solution and Service Table 26. Date of Enter into NASH Therapeutic Drugs Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global NASH Therapeutic Drugs Market Size by Type (2015-2020) (Million US$) Table 29. Global NASH Therapeutic Drugs Market Size Share by Type (2015-2020) Table 30. Global NASH Therapeutic Drugs Revenue Market Share by Type (2021-2026) Table 31. Global NASH Therapeutic Drugs Market Size Share by Application (2015-2020) Table 32. Global NASH Therapeutic Drugs Market Size by Application (2015-2020) (Million US$) Table 33. Global NASH Therapeutic Drugs Market Size Share by Application (2021-2026) Table 34. North America Key Players NASH Therapeutic Drugs Revenue (2019-2020) (Million US$) Table 35. North America Key Players NASH Therapeutic Drugs Market Share (2019-2020) Table 36. North America NASH Therapeutic Drugs Market Size by Type (2015-2020) (Million US$) Table 37. North America NASH Therapeutic Drugs Market Share by Type (2015-2020) Table 38. North America NASH Therapeutic Drugs Market Size by Application (2015-2020) (Million US$) Table 39. North America NASH Therapeutic Drugs Market Share by Application (2015-2020) Table 40. Europe Key Players NASH Therapeutic Drugs Revenue (2019-2020) (Million US$) Table 41. Europe Key Players NASH Therapeutic Drugs Market Share (2019-2020) Table 42. Europe NASH Therapeutic Drugs Market Size by Type (2015-2020) (Million US$) Table 43. Europe NASH Therapeutic Drugs Market Share by Type (2015-2020) Table 44. Europe NASH Therapeutic Drugs Market Size by Application (2015-2020) (Million US$) Table 45. Europe NASH Therapeutic Drugs Market Share by Application (2015-2020) Table 46. China Key Players NASH Therapeutic Drugs Revenue (2019-2020) (Million US$) Table 47. China Key Players NASH Therapeutic Drugs Market Share (2019-2020) Table 48. China NASH Therapeutic Drugs Market Size by Type (2015-2020) (Million US$) Table 49. China NASH Therapeutic Drugs Market Share by Type (2015-2020) Table 50. China NASH Therapeutic Drugs Market Size by Application (2015-2020) (Million US$) Table 51. China NASH Therapeutic Drugs Market Share by Application (2015-2020) Table 52. Japan Key Players NASH Therapeutic Drugs Revenue (2019-2020) (Million US$) Table 53. Japan Key Players NASH Therapeutic Drugs Market Share (2019-2020) Table 54. Japan NASH Therapeutic Drugs Market Size by Type (2015-2020) (Million US$) Table 55. Japan NASH Therapeutic Drugs Market Share by Type (2015-2020) Table 56. Japan NASH Therapeutic Drugs Market Size by Application (2015-2020) (Million US$) Table 57. Japan NASH Therapeutic Drugs Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players NASH Therapeutic Drugs Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players NASH Therapeutic Drugs Market Share (2019-2020) Table 60. Southeast Asia NASH Therapeutic Drugs Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia NASH Therapeutic Drugs Market Share by Type (2015-2020) Table 62. Southeast Asia NASH Therapeutic Drugs Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia NASH Therapeutic Drugs Market Share by Application (2015-2020) Table 64. India Key Players NASH Therapeutic Drugs Revenue (2019-2020) (Million US$) Table 65. India Key Players NASH Therapeutic Drugs Market Share (2019-2020) Table 66. India NASH Therapeutic Drugs Market Size by Type (2015-2020) (Million US$) Table 67. India NASH Therapeutic Drugs Market Share by Type (2015-2020) Table 68. India NASH Therapeutic Drugs Market Size by Application (2015-2020) (Million US$) Table 69. India NASH Therapeutic Drugs Market Share by Application (2015-2020) Table 70. Central & South America Key Players NASH Therapeutic Drugs Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players NASH Therapeutic Drugs Market Share (2019-2020) Table 72. Central & South America NASH Therapeutic Drugs Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America NASH Therapeutic Drugs Market Share by Type (2015-2020) Table 74. Central & South America NASH Therapeutic Drugs Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America NASH Therapeutic Drugs Market Share by Application (2015-2020) Table 76. Allergan Plc (Tobira) Company Details Table 77. Allergan Plc (Tobira) Business Overview Table 78. Allergan Plc (Tobira) Product Table 79. Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2015-2020) (Million US$) Table 80. Allergan Plc (Tobira) Recent Development Table 81. Bristol Myers Squibb Company Details Table 82. Bristol Myers Squibb Business Overview Table 83. Bristol Myers Squibb Product Table 84. Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2015-2020) (Million US$) Table 85. Bristol Myers Squibb Recent Development Table 86. Galmed Pharmaceuticals Company Details Table 87. Galmed Pharmaceuticals Business Overview Table 88. Galmed Pharmaceuticals Product Table 89. Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2015-2020) (Million US$) Table 90. Galmed Pharmaceuticals Recent Development Table 91. Genfit SA Company Details Table 92. Genfit SA Business Overview Table 93. Genfit SA Product Table 94. Genfit SA Revenue in NASH Therapeutic Drugs Business (2015-2020) (Million US$) Table 95. Genfit SA Recent Development Table 96. Gilead Sciences, Inc. Company Details Table 97. Gilead Sciences, Inc. Business Overview Table 98. Gilead Sciences, Inc. Product Table 99. Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2015-2020) (Million US$) Table 100. Gilead Sciences, Inc. Recent Development Table 101. Intercept Pharmaceuticals, Inc. Company Details Table 102. Intercept Pharmaceuticals, Inc. Business Overview Table 103. Intercept Pharmaceuticals, Inc. Product Table 104. Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2015-2020) (Million US$) Table 105. Intercept Pharmaceuticals, Inc. Recent Development Table 106. Zydus Cadila Company Details Table 107. Zydus Cadila Business Overview Table 108. Zydus Cadila Product Table 109. Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2015-2020) (Million US$) Table 110. Zydus Cadila Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global NASH Therapeutic Drugs Market Share by Type: 2020 VS 2026 Figure 2. Vitamin E and Pioglitazone Features Figure 3. Ocaliva Features Figure 4. Elafibranor Features Figure 5. Selonsertib and Cenicriviroc Features Figure 6. Global NASH Therapeutic Drugs Market Share by Application: 2020 VS 2026 Figure 7. Hospital Pharmacy Case Studies Figure 8. Online Provider Case Studies Figure 9. Retail Pharmacy Case Studies Figure 10. NASH Therapeutic Drugs Report Years Considered Figure 11. Global NASH Therapeutic Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global NASH Therapeutic Drugs Market Share by Regions: 2020 VS 2026 Figure 13. Global NASH Therapeutic Drugs Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global NASH Therapeutic Drugs Market Share by Players in 2019 Figure 16. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NASH Therapeutic Drugs as of 2019 Figure 17. The Top 10 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2019 Figure 18. North America NASH Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe NASH Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China NASH Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan NASH Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia NASH Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India NASH Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America NASH Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Allergan Plc (Tobira) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Allergan Plc (Tobira) Revenue Growth Rate in NASH Therapeutic Drugs Business (2015-2020) Figure 27. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Bristol Myers Squibb Revenue Growth Rate in NASH Therapeutic Drugs Business (2015-2020) Figure 29. Galmed Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Galmed Pharmaceuticals Revenue Growth Rate in NASH Therapeutic Drugs Business (2015-2020) Figure 31. Genfit SA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Genfit SA Revenue Growth Rate in NASH Therapeutic Drugs Business (2015-2020) Figure 33. Gilead Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Gilead Sciences, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2015-2020) Figure 35. Intercept Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2015-2020) Figure 37. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Zydus Cadila Revenue Growth Rate in NASH Therapeutic Drugs Business (2015-2020) Figure 39. Bottom-up and Top-down Approaches for This Report Figure 40. Data Triangulation Figure 41. Key Executives Interviewed

Allergan Plc (Tobira) Bristol Myers Squibb Galmed Pharmaceuticals Genfit SA Gilead Sciences, Inc. Intercept Pharmaceuticals, Inc. Zydus Cadila